Best Supplements to Take With Tesofensine

Tesofensine Runs on Monoamines, and Monoamines Need Raw Materials

Tesofensine is not a GLP-1 drug, not a traditional stimulant, and not an antidepressant, even though it resembles all three from certain angles. It is a triple monoamine reuptake inhibitor, which means it blocks the transporters that normally pull dopamine, norepinephrine, and serotonin back out of the synapse after they fire. With those three transporters blocked, all three neurotransmitters linger at higher concentrations. That elevated tone tells the brain it is not hungry, raises energy expenditure, and produces the weight loss the compound is known for through a mechanism that is entirely central rather than gut-based.

The distinction from GLP-1 agonists like semaglutide matters for this article because the mechanism shapes everything downstream. GLP-1 drugs work at incretin receptors in the gut and along the vagus nerve, the long nerve connecting the gut to the brain, and their nausea comes from genuinely slowed gastric emptying. Tesofensine's nausea is centrally mediated, triggered in the brain's chemoreceptor zone rather than in the stomach, which is why the side effects that actually need managing are insomnia, anxiety, and cardiovascular stimulation rather than prolonged vomiting. The supplement logic is correspondingly different.

Here is the dependency the stack is built around. Dopamine is synthesized from the amino acid tyrosine. Serotonin is synthesized from tryptophan. Norepinephrine is made from dopamine. Each of those synthesis steps requires specific cofactors, most importantly active vitamin B6, iron, and vitamin D, to run at full speed. When tesofensine blocks reuptake, it extends the time each monoamine molecule spends in the synapse, but it does not create new monoamine molecules. The rate of synthesis still sets the ceiling. A person running tesofensine with poor B-vitamin status, low iron, or deficient vitamin D is asking the compound to preserve a pool that the body cannot fully replenish. The result looks like a weaker-than-expected response.

The second problem is what the compound does to total food intake. Tesofensine is a strong appetite suppressant, which is the point, but a strong appetite suppressant cuts dietary intake of everything, not just calories. B vitamins, magnesium, and iron all follow total food intake down. The same population most likely to use tesofensine, people carrying substantial excess weight, also tends to arrive with low circulating vitamin D because adipose tissue sequesters it, with low ferritin because chronic inflammation in obesity raises a hormone called hepcidin that blocks intestinal iron absorption, and with suboptimal magnesium intake. The compound's success can quietly deepen deficiencies that limit it.

On the stimulant side, tesofensine's dominant pharmacological target is the norepinephrine transporter, where it is considerably more potent than at the dopamine transporter. Norepinephrine is the neurotransmitter most directly responsible for the sympathetic nervous system's accelerator pedal. More norepinephrine in the synapse means faster heart rate, lighter sleep, and a nervous energy that some users find manageable and others find intolerable. This is the side-effect cluster that distinguishes tesofensine from GLP-1 drugs entirely and from bupropion, its closest small-molecule sibling, by degree: bupropion lacks the serotonin arm and produces a more modest cardiovascular footprint. Magnesium and L-theanine both address tesofensine's characteristic stimulant profile through specific mechanisms, not as generic calming supplements.

The Supplements That Matter on Tesofensine

There are no dose numbers on this page. The right amount of each supplement depends on your actual tesofensine protocol, your current bloodwork, and what else you are already taking. A flat number printed for the average person would be wrong for almost every specific one. MyPeptidePal takes those variables into account and works out the amounts that make sense for you.

Fix These Before You Blame the Compound

Tesofensine is doing something specific in the brain: raising the concentration of three neurotransmitters by slowing how fast they are cleared from the synapse. But it cannot manufacture those neurotransmitters. That job still belongs to the body's synthesis machinery, and that machinery is bottlenecked by a small set of nutrients commonly low in the people most likely to be running this compound. Correcting these deficiencies does not add a new benefit on top of tesofensine. It removes a ceiling that is limiting what tesofensine can already do.

B-complex (B6, B12, and folate)

This trio functions as a practical unit for tesofensine users, and understanding why all three matter is more useful than knowing just one.

Active vitamin B6, in the form the body actually uses called pyridoxal-5-phosphate, is the required cofactor for the enzyme that converts amino acid building blocks into serotonin and dopamine. Think of this enzyme as the assembly worker that attaches the right chemical group to the raw material. Without enough B6, that worker slows down, and the monoamine pool that tesofensine is working to preserve shrinks at its source. Vitamin B12 and folate are both required to keep the methylation cycle running. The methylation cycle is a biochemical recycling loop that converts a potentially harmful amino acid called homocysteine back into useful compounds. When this cycle stalls because B12 or folate is short, homocysteine accumulates. That matters specifically on tesofensine because the compound already places a mild burden on the cardiovascular system through its norepinephrine effects, and elevated homocysteine adds to that cardiovascular burden through a separate pathway.

The practical connection to tesofensine is direct. Appetite suppression cuts total food intake, and animal protein, leafy greens, and fortified foods, the main dietary sources of all three B-vitamins, fall with it. Someone running tesofensine for several months who starts with borderline B-vitamin status is likely to end that period genuinely deficient. The form matters here in ways that are worth understanding. B6 as pyridoxal-5-phosphate rather than standard pyridoxine skips a conversion step that a meaningful proportion of people perform poorly due to common genetic variation. B12 as methylcobalamin rather than cyanocobalamin enters circulation more directly. Folate as methylfolate rather than synthetic folic acid avoids a related conversion bottleneck.

One important note about SAMe, the supplement some people use for mood support: SAMe is the methyl donor this same pathway produces, and supplementing it directly on tesofensine adds serotonergic load on top of what the compound is already creating through serotonin transporter blockade. The safer path is ensuring adequate B6, B12, and folate so the body makes SAMe at the rate it needs, rather than adding it in a concentrated supplemental form. This is covered in the cautions section.

Because B-complex addresses both the monoamine substrate supply and the cardiovascular risk from homocysteine accumulation, it earns double-duty status on this compound.

Iron

Iron is not a nutrient most people associate with neurotransmitters, but the link here is direct and specific. The two enzymes responsible for making dopamine and serotonin, called tyrosine hydroxylase and tryptophan hydroxylase, both require iron to function. They are the rate-limiting step in their respective synthesis pathways, meaning the speed of the entire pathway is set by how quickly these enzymes work. When iron is low, both pathways slow down, and the monoamine pool available for tesofensine to work with becomes smaller.

The deficiency pattern in the population most likely to be using tesofensine makes this lever particularly relevant. Obesity is associated with chronic low-grade inflammation, and that inflammation raises a hormone called hepcidin, which directly blocks intestinal iron absorption and prevents stored iron from being mobilized into circulation. The result is functional iron deficiency even in people eating adequate dietary iron, because the body's own regulatory system is suppressing absorption. Ferritin, the storage protein that is the best routine marker for iron status, can be falsely elevated by inflammation in obesity, so checking it alongside an inflammation marker gives a more accurate reading.

Iron supplementation should be confirmed by bloodwork before starting. Unnecessary iron intake causes gastrointestinal distress and contributes to oxidative stress, and it is not appropriate as a prophylactic. But for someone whose ferritin is genuinely low, this correction directly restores the cofactors the neurotransmitter synthesis enzymes need. Ferrous bisglycinate is the most gut-friendly form, and taking iron with vitamin C while separating it from calcium and zinc, which compete for absorption at the same intestinal transporter, meaningfully improves uptake.

Vitamin D3

Vitamin D receptors are distributed throughout the brain, including in the regions where dopamine and serotonin neurons are concentrated. Research in these neurons shows that vitamin D plays a regulatory role in the activity of the synthesis enzymes for both neurotransmitters. Deficiency does not shut down synthesis entirely, but it measurably reduces how efficiently those enzymes run.

The population-level pattern is specific and worth understanding. Vitamin D is fat-soluble, and adipose tissue sequesters it. As body fat increases, the proportion of vitamin D that circulates in the blood decreases, even with identical sun exposure or dietary intake. Someone carrying substantial excess weight can have adequate total-body vitamin D but genuinely low circulating levels, which are what neurons actually use. This means the primary population for tesofensine tends to arrive with a vitamin D gap that is not a diet problem in the ordinary sense.

Tesofensine's mild cardiovascular burden, from its norepinephrine transporter blockade raising heart rate and blood pressure modestly, also argues for pairing vitamin D3 with vitamin K2 in the MK-7 form. K2 directs calcium toward bone and away from arterial walls, which becomes relevant when a compound is placing sustained upward pressure on both heart rate and blood pressure over months of use. Vitamin D3 is fat-soluble and is absorbed considerably better with a meal containing fat.

Managing Tesofensine's Stimulant Profile

Tesofensine is not a GLP-1 drug, and its side-effect profile reflects that completely. The two effects that most commonly push people toward dose reductions or early discontinuation are insomnia and the anxious, wired quality that comes with elevated norepinephrine and dopamine. These are not incidental to the compound. They follow directly from its pharmacology. The norepinephrine transporter is tesofensine's strongest target by a significant margin, and norepinephrine drives the sympathetic nervous system's accelerator function. More norepinephrine in the synapse means faster heart rate, lighter sleep, and a nervous edge that some users find manageable and others do not. The supplements in this section address that profile through specific mechanisms.

L-theanine

L-theanine is an amino acid found in tea leaves that raises alpha brain-wave activity, the pattern associated with relaxed alertness, and supports the brain's primary inhibitory signaling system. It blunts the anxious, wired quality that tesofensine's norepinephrine elevation produces, without sedating the user or meaningfully reducing the appetite suppression that is the point of the compound.

Controlled trials have examined L-theanine's effect on anxiety and stress, and while most of that work was not conducted specifically in the context of monoamine reuptake inhibition, the mechanism is sound and the effect is consistent across settings where catecholamine-driven arousal is the problem. Users who find the morning dose of tesofensine produces excess nervous energy or noticeable heart rate awareness tend to report that L-theanine taken at the same time takes the edge off without reducing the weight-loss effect.

This is meaningfully different from using a sedative or a beta-blocker for the same symptoms. Both of those approaches suppress sympathetic activation broadly, which carries its own costs. L-theanine works at the level of inhibitory neurotransmission rather than at the receptor for norepinephrine itself, which is why it smooths the edge rather than blunting the therapeutic effect.

Magnesium

Magnesium earns double-duty status on tesofensine, appearing in both the deficiency gate section and here. This section covers its side-effect mitigation role specifically.

Magnesium regulates the activity of a brain receptor called the NMDA receptor, which is involved in excitatory signaling. Think of it as a dimmer on the brain's excitation circuit. When magnesium levels are low, that dimmer is turned up, neural excitability increases, and the result is worsened anxiety, more difficulty falling asleep, and greater sensitivity to the cardiovascular effects of stimulant-type compounds. Tesofensine is already raising norepinephrine and dopamine. A magnesium deficit removes the brake that would otherwise keep that excitation in a tolerable range.

The glycinate form taken in the evening is the correct choice for this application. Glycinate is well-absorbed, does not cause the laxative effect common with oxide forms, and the evening timing means it is working during the hours when tesofensine's stimulant effect is declining and sleep becomes the priority. Insomnia and anxiety that respond to magnesium correction are nutritional problems with a nutritional fix, not pharmacological side effects requiring dose reduction.

Serum magnesium is not a reliable test for whether someone is actually magnesium-replete. The body keeps serum levels tightly buffered by drawing from bone, so serum can look normal while tissue stores are genuinely depleted. RBC magnesium, which measures magnesium inside red blood cells rather than in the surrounding fluid, reflects actual tissue status and is the more useful marker when magnesium sufficiency is in question.

Electrolytes

Tesofensine's appetite suppression is strong enough that users often notice a significant reduction in how much food and fluid they want each day. Sodium, potassium, and magnesium all follow total intake down, and the fatigue, headaches, and muscle cramps that result from that shortfall are frequently attributed to the compound rather than recognized as a correctable nutritional problem.

The dry mouth side effect compounds this directly. It is caused by the noradrenergic effect of norepinephrine transporter blockade reducing salivary secretion, and users who experience it often drink less fluid than usual because swallowing becomes slightly uncomfortable. Less fluid means less opportunity to replace electrolytes already running low from reduced food intake. The resulting fatigue and cognitive dullness end up on the compound's side-effect list, but they are an electrolyte problem with a straightforward fix.

A low-sugar electrolyte product or deliberate attention to sodium and potassium from food sources is usually sufficient. The key is recognizing that this depletion pattern is a predictable consequence of tesofensine's mechanism rather than an idiosyncratic reaction, and addressing it proactively rather than after the fatigue appears.

Protecting What the Deficit Would Otherwise Take

Tesofensine produces weight loss by creating a significant caloric deficit through appetite suppression. That deficit is not selective. The body draws energy from both fat and lean tissue when calories fall sharply, and the proportion drawn from lean tissue is higher than most people expect. Studies of caloric-restriction weight loss consistently show that a substantial fraction of weight lost without protein and resistance training support comes from lean mass rather than fat. Tesofensine's weight loss is large enough that the absolute amount of lean mass at risk is real. The two supplements here address that risk through distinct and complementary mechanisms.

Protein (leucine-rich)

Protein is the most evidence-backed intervention for preserving lean mass during weight loss, and the evidence here comes from controlled human trials rather than mechanistic reasoning alone. Adequate dietary protein, particularly protein rich in the amino acid leucine, signals muscle protein synthesis to continue even when total calorie intake is below what the body needs for maintenance. Leucine specifically activates the molecular switch for muscle protein synthesis, and consistently meeting the leucine threshold is what separates a weight loss that is mostly fat from one that takes significant muscle with it.

The challenge on tesofensine is that appetite suppression makes meeting protein targets harder. A person who is not hungry does not want to eat, and protein is calorie-dense and satiating. The practical result is that protein intake falls farthest among all macronutrients when a strong appetite suppressant is running. A leucine-rich protein supplement, such as whey or a comparable complete plant-based blend, delivers the amino acid signal for muscle preservation in a concentrated form that is easier to consume when appetite is genuinely low.

Creatine Monohydrate

Creatine works through a different mechanism than protein, and the two work better together than either does alone. Creatine is stored in muscle tissue and replenishes the energy molecule used for high-intensity contractions in the first few seconds of effort. Picture a short-duration power reserve that the muscle draws on before slower energy systems can catch up. In a caloric deficit, the general energy available to muscle decreases, which tends to lower training intensity, which in turn weakens the signal for muscle to be maintained. Creatine partially compensates for that reduced energy availability by extending how long the muscle can sustain high-intensity output before fatigue sets in.

The clinical evidence for creatine monohydrate in resistance training contexts is among the most consistent in sports nutrition research, and there is growing evidence specifically in weight-loss contexts showing that it helps retain lean mass in a deficit compared to training without it. The monohydrate form is the standard, and all the established research was conducted on this form. Timing is workout-dependent rather than tesofensine-dependent: it does not need to be timed around the morning compound dose and performs best scheduled around training sessions.

Cautions and Interactions

The single most important safety point for anyone running tesofensine is this: tesofensine must never be combined with MAO inhibitors. MAO inhibitors are a class of medications, including phenelzine, tranylcypromine, selegiline, linezolid, and methylene blue, that prevent the enzymes responsible for breaking down monoamines from doing their job. Tesofensine prevents monoamines from being cleared from the synapse. Together, these two mechanisms cause monoamine levels to build to catastrophic concentrations, producing a condition called serotonin syndrome that can include seizures, extremely high body temperature, and cardiovascular collapse. This combination is potentially fatal and is an absolute contraindication with no safe window. Do not take tesofensine within two weeks of stopping an MAOI, and do not start an MAOI while on tesofensine.

SSRIs and SNRIs represent a serious risk rather than a fatal one, but they are not a minor caution. SSRIs block the serotonin transporter, which is one of the three targets tesofensine is already blocking. The combined serotonin accumulation can produce serotonin syndrome, with symptoms including muscle twitching, agitation, sweating, and elevated heart rate that can progress in severe cases to dangerous hyperthermia and altered consciousness. SNRIs add norepinephrine transporter blockade on top of that, creating both serotonergic and cardiovascular additive strain. Anyone already on an SSRI or SNRI and considering tesofensine should discuss this with a prescribing clinician. This is not a supplement timing question.

Among supplements specifically, 5-HTP and St. John's Wort are both interactions to take seriously. 5-HTP is a direct precursor to serotonin: it sits one chemical step away from serotonin in the synthesis pathway. Flooding that pathway while the serotonin transporter is blocked by tesofensine is a clear serotonin syndrome mechanism, not a theoretical one. St. John's Wort carries two separate problems: it has mild serotonin transporter inhibiting activity that adds to tesofensine's serotonergic burden, and it also activates liver enzymes that clear tesofensine from the bloodstream, making plasma levels unpredictable. Either problem alone would be a caution; together they make St. John's Wort a supplement to eliminate entirely while on this compound.

Stimulants and sympathomimetic compounds, including yohimbine, high-dose caffeine, ephedrine, pseudoephedrine, and DMAA, combine problematically with tesofensine's norepinephrine effect. Tesofensine is already raising heart rate and blood pressure modestly through norepinephrine transporter blockade. Adding another agent driving the same system amplifies that cardiovascular load into territory where hypertensive urgency, arrhythmia, and serious adverse events become realistic rather than theoretical risks. Moderate caffeine earlier in the day carries lower risk than high doses or afternoon use, but the direction of the interaction is always the same.

Bupropion, sold as Wellbutrin, is worth flagging specifically because it is prescribed for both depression and weight management. It blocks the norepinephrine and dopamine transporters, creating direct pharmacological overlap with tesofensine at two of its three targets. Combining them risks additive psychiatric and cardiovascular effects that go beyond either compound alone.

SAMe, an over-the-counter supplement used for mood support, raises serotonergic load and should be avoided while on tesofensine. If the goal is supporting the methylation cycle that SAMe feeds, the safer approach is ensuring adequate B6, B12, and folate, which give the body the cofactors it needs to make SAMe at the rate it requires, rather than adding it directly in a concentrated supplemental form that can push serotonin too high.

Blood pressure medications deserve attention for people already taking them. Tesofensine raises blood pressure modestly through norepinephrine, which can work against antihypertensive medications including beta-blockers, ACE inhibitors, and calcium channel blockers. This is a monitoring question rather than a contraindication, but it requires awareness and regular blood pressure checks rather than the assumption that the antihypertensive is fully compensating.

Frequently Asked Questions

How much of each supplement should I take with tesofensine?

There are no dose numbers on this page, and that is intentional rather than an oversight. The right amount of each supplement depends on your current bloodwork, your specific tesofensine protocol, your body weight, and what else you are already taking. A number that works for one person is wrong for another, and printing a flat number here would give most readers a figure that does not fit their situation. MyPeptidePal takes those variables into account and builds a personalized plan from them.

Which blood markers matter most when running tesofensine?

The most directly relevant markers are ferritin for iron stores, RBC magnesium rather than serum magnesium, 25-OH-D for vitamin D status, and homocysteine as a functional indicator of B6, B12, and folate adequacy. Heart rate and blood pressure should also be tracked at baseline and during titration, since tesofensine raises both through its norepinephrine mechanism. These reflect the specific nutritional gaps this compound creates and the cardiovascular burden it places, rather than being a comprehensive blood panel requirement.

Do any of these supplements reduce how well tesofensine works?

None of the supplements recommended in this guide interfere with tesofensine's appetite-suppressing or weight-loss mechanism. L-theanine blunts the stimulant edge rather than the therapeutic effect. Magnesium, B-complex, protein, and creatine all operate at the nutritional and structural level rather than at the monoamine transporter level where tesofensine works. The interactions to avoid are the ones in the cautions section, particularly serotonergic supplements like 5-HTP and stimulant compounds like yohimbine, which compound the compound's side effects rather than reduce its efficacy.

Do I need to keep taking these supplements after I stop tesofensine?

The deficiency corrections, particularly B-complex, magnesium, iron, and vitamin D, address shortfalls that were likely present before tesofensine and will persist after it unless diet improves substantially. Those are worth maintaining. Protein and creatine remain relevant for anyone continuing resistance training, which is the activity that makes the preserved lean mass worth keeping. L-theanine and the electrolyte attention are specific to managing tesofensine's stimulant side effects and can be stepped back when the compound is stopped.

Can I replace all of this with a good multivitamin?

A multivitamin addresses the general nutritional baseline, but it does not deliver the specific forms or quantities this compound's support requires. Standard multivitamins typically contain pyridoxine rather than the active pyridoxal-5-phosphate form of B6, cyanocobalamin rather than methylcobalamin for B12, synthetic folic acid rather than methylfolate, and very little magnesium in a poorly absorbed form. They contain no protein and no creatine. The value of the supplements on this list comes from targeting mechanisms specific to tesofensine's pharmacology, not from general nutritional insurance.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of Tesofensine and the nutrients that support it in one place.